Seroatlas · Human Serome Atlas

CSRNP1

Cysteine/serine-rich nuclear protein 1

Also known as: AXUD1, CSRN1_HUMAN, DKFZp566F164, FAM130B, TAIP-3, URAX1

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q96S65
Gene
CSRNP1
Ensembl
ENSG00000144655
Chromosome
3
Canonical length
589 aa
Protein class
Predicted intracellular proteins, Transcription factors
Subcellular location
Nucleoplasm,Vesicles

OverviewNCBI Gene

This gene encodes a protein that localizes to the nucleus and expression of this gene is induced in response to elevated levels of axin. The Wnt signalling pathway, which is negatively regulated by axin, is important in axis formation in early development and impaired regulation of this signalling pathway is often involved in tumors. A decreased level of expression of this gene in tumors compared to the level of expression in their corresponding normal tissues suggests that this gene product has a tumor suppressor function. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

Canonical amino-acid sequenceUniProt

589 residues, UniProt reviewed canonical sequence.

>Q96S65|CSRNP1
     1  MTGLLKRKFD QLDEDNSSVS SSSSSSGCQS RSCSPSSSVS RAWDSEEEGP WDQMPLPDRD
    61  FCGPRSFTPL SILKRARRER PGRVAFDGIT VFYFPRCQGF TSVPSRGGCT LGMALRHSAC
   121  RRFSLAEFAQ EQARARHEKL RQRLKEEKLE MLQWKLSAAG VPQAEAGLPP VVDAIDDASV
   181  EEDLAVAVAG GRLEEVSFLQ PYPARRRRAL LRASGVRRID REEKRELQAL RQSREDCGCH
   241  CDRICDPETC SCSLAGIKCQ MDHTAFPCGC CREGCENPMG RVEFNQARVQ THFIHTLTRL
   301  QLEQEAESFR ELEAPAQGSP PSPGEEALVP TFPLAKPPMN NELGDNSCSS DMTDSSTASS
   361  SASGTSEAPD CPTHPGLPGP GFQPGVDDDS LARILSFSDS DFGGEEEEEE EGSVGNLDNL
   421  SCFHPADIFG TSDPGGLASW THSYSGCSFT SGVLDENANL DASCFLNGGL EGSREGSLPG
   481  TSVPPSMDAG RSSSVDLSLS SCDSFELLQA LPDYSLGPHY TSQKVSDSLD NIEAPHFPLP
   541  GLSPPGDASS CFLESLMGFS EPAAEALDPF IDSQFEDTVP ASLMEPVPV

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CSRNP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.58
Highest tissue expression
182 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 182 nTPM
  • adipose tissue: 84 nTPM
  • lung: 75 nTPM
  • fallopian tube: 66 nTPM
  • gallbladder: 63 nTPM
  • liver: 61 nTPM

Single-cell type

  • neutrophils: 382 nCPM
  • endometrial luminal cells: 240 nCPM
  • epididymal basal cells: 235 nCPM
  • endometrial glandular cells: 211 nCPM
  • breast secretory cells: 202 nCPM
  • smooth muscle cells: 184 nCPM

Immune cell

  • neutrophil: 17 nTPM
  • non-classical monocyte: 11 nTPM
  • intermediate monocyte: 5.9 nTPM
  • plasmacytoid DC: 4.2 nTPM
  • eosinophil: 3.8 nTPM
  • naive B-cell: 3.7 nTPM

Brain region

  • cerebral cortex: 34 nTPM
  • medulla oblongata: 32 nTPM
  • spinal cord: 26 nTPM
  • hypothalamus: 25 nTPM
  • thalamus: 23 nTPM
  • cerebellum: 23 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.53
gnomAD pLI
0.34
gnomAD missense Z
0.29
DepMap mean gene effect
-0.01
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CSRNP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CSRNP1 as an antibody target. Whether an autoantibody or antibody against CSRNP1 could matter depends on whether native CSRNP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CSRNP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CSRNP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CSRNP1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...